A citation-based method for searching scientific literature

Osman Shabir, Tobias A Moll, Martyna M Matuszyk, Beth Eyre, Manmohi D Dake, Jason Berwick, Sheila E Francis. Mech Ageing Dev 2020
Times Cited: 3







List of co-cited articles
1 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity



Find drugs that delay many diseases of old age.
Ilaria Bellantuono. Nature 2018
16
33

Predicting negative health outcomes in older general practice patients with chronic illness: Rationale and development of the PROPERmed harmonized individual participant data database.
Ana I González-González, Truc S Dinh, Andreas D Meid, Jeanet W Blom, Marjan van den Akker, Petra J M Elders, Ulrich Thiem, Daniela Kuellenberg de Gaudry, Kym I E Snell, Rafael Perera,[...]. Mech Ageing Dev 2021
2
50

Training primary care professionals in multimorbidity management: Educational assessment of the eMULTIPAP course.
Francisca Leiva-Fernández, Juan Daniel Prados-Torres, Alexandra Prados-Torres, Isabel Del-Cura-González, Marcos Castillo-Jimena, Juan Antonio López-Rodríguez, Maria Eloísa Rogero-Blanco, Cristina M Lozano-Hernández, Fernando López-Verde, María José Bujalance-Zafra,[...]. Mech Ageing Dev 2020
5
33

Multimorbidity networks of chronic obstructive pulmonary disease and heart failure in men and women: Evidence from the EpiChron Cohort.
Jonás Carmona-Pírez, Beatriz Poblador-Plou, Jesús Díez-Manglano, Manuel Jesús Morillo-Jiménez, José María Marín Trigo, Ignatios Ioakeim-Skoufa, Antonio Gimeno-Miguel, Alexandra Prados-Torres. Mech Ageing Dev 2021
6
33

Facing multimorbidity in the precision medicine era.
Graziano Onder, Roberto Bernabei, Davide L Vetrano, Katie Palmer, Alessandra Marengoni. Mech Ageing Dev 2020
6
33

Untangling the complexity of multimorbidity with machine learning.
Abdelaali Hassaine, Gholamreza Salimi-Khorshidi, Dexter Canoy, Kazem Rahimi. Mech Ageing Dev 2020
11
33

3
33

The use of geroprotectors to prevent multimorbidity: Opportunities and challenges.
Samir Morsli, Ilaria Bellantuono. Mech Ageing Dev 2021
6
33

Associations of multimorbidity on frailty and dependence among an elderly rural population: Findings from the AHSETS study.
Jaya Singh Kshatri, Subrata Kumar Palo, Trilochan Bhoi, Shakti Ranjan Barik, Sanghamitra Pati. Mech Ageing Dev 2020
6
33

The complex interplay between depression and multimorbidity in late life: risks and pathways.
Federico Triolo, Lisa Harber-Aschan, Martino Belvederi Murri, Amaia Calderón-Larrañaga, Davide L Vetrano, Linnea Sjöberg, Alessandra Marengoni, Serhiy Dekhtyar. Mech Ageing Dev 2020
16
33

Repulsive Guidance Molecule a (RGMa) Induces Neuropathological and Behavioral Changes That Closely Resemble Parkinson's Disease.
Joanna A Korecka, Elizabeth B Moloney, Ruben Eggers, Barbara Hobo, Sanny Scheffer, Nienke Ras-Verloop, R Jeroen Pasterkamp, Dick F Swaab, August B Smit, Ronald E van Kesteren,[...]. J Neurosci 2017
16
33

Diagnostic staging of Parkinson's disease: conceptual aspects.
H Przuntek, Th Müller, P Riederer. J Neural Transm (Vienna) 2004
105
33


Repulsive guidance molecule-a and demyelination: implications for multiple sclerosis.
Takekazu Kubo, Shigeru Tokita, Toshihide Yamashita. J Neuroimmune Pharmacol 2012
12
33

Delaying memory decline: different options and emerging solutions.
Felicitas Schneider, Alan Horowitz, Klaus-Peter Lesch, Thomas Dandekar. Transl Psychiatry 2020
5
33

Treating Parkinson's Disease with Antibodies: Previous Studies and Future Directions.
Anne-Marie Castonguay, Claude Gravel, Martin Lévesque. J Parkinsons Dis 2021
9
33

Clinical progression in Parkinson disease and the neurobiology of axons.
Hsiao-Chun Cheng, Christina M Ulane, Robert E Burke. Ann Neurol 2010
499
33


Levodopa increases oxidative stress and repulsive guidance molecule A levels: a pilot study in patients with Parkinson's disease.
Thomas Müller, Isabel Trommer, Siegfried Muhlack, Bernhard K Mueller. J Neural Transm (Vienna) 2016
24
33


Neuroinflammation - a common thread in neurological disorders.
Nils Erik Gilhus, Günther Deuschl. Nat Rev Neurol 2019
56
33

Brain Microglial Activation Increased in Glucocerebrosidase (GBA) Mutation Carriers without Parkinson's disease.
Stephen Mullin, Morten Gersel Stokholm, Derralyn Hughes, Atul Mehta, Peter Parbo, Rainer Hinz, Nicola Pavese, David J Brooks, Anthony H V Schapira. Mov Disord 2021
20
33


Repulsive guidance molecules lock growth differentiation factor 5 in an inhibitory complex.
Tomas Malinauskas, Tina V Peer, Benjamin Bishop, Thomas D Mueller, Christian Siebold. Proc Natl Acad Sci U S A 2020
8
33

History of levodopa and dopamine agonists in Parkinson's disease treatment.
E Tolosa, M J Martí, F Valldeoriola, J L Molinuevo. Neurology 1998
76
33

Coronaviruses: a challenge of today and a call for extended human postmortem brain analyses.
Peter Riederer, Volker Ter Meulen. J Neural Transm (Vienna) 2020
15
33

Alzheimer's disease.
C A Lane, J Hardy, J M Schott. Eur J Neurol 2018
821
33

Parkinson's disease and pesticides: A meta-analysis of disease connection and genetic alterations.
Hussien Ahmed, Abdelrahman Ibrahim Abushouk, Mohamed Gabr, Ahmed Negida, Mohamed M Abdel-Daim. Biomed Pharmacother 2017
51
33

Stem Cell-Based Therapies for Parkinson Disease.
Zhaohui Liu, Hoi-Hung Cheung. Int J Mol Sci 2020
14
33


Human-induced pluripotent stem cells pave the road for a better understanding of motor neuron disease.
Beate Winner, Maria C Marchetto, Jürgen Winkler, Fred H Gage. Hum Mol Genet 2014
16
33

Influenza vaccination in early Alzheimer's disease rescues amyloidosis and ameliorates cognitive deficits in APP/PS1 mice by inhibiting regulatory T cells.
Yunjie Yang, Zitian He, Zhiwei Xing, Zejie Zuo, Lifang Yuan, Yingying Wu, Mei Jiang, Fangfang Qi, Zhibin Yao. J Neuroinflammation 2020
14
33

The burden of neurological diseases in Europe: an analysis for the Global Burden of Disease Study 2017.
Günther Deuschl, Ettore Beghi, Franz Fazekas, Timea Varga, Kalliopi A Christoforidi, Eveline Sipido, Claudio L Bassetti, Theo Vos, Valery L Feigin. Lancet Public Health 2020
100
33

Repulsive Guidance Molecule A Suppresses Adult Neurogenesis.
Toke Jost Isaksen, Yuki Fujita, Toshihide Yamashita. Stem Cell Reports 2020
5
33


A double-blind controlled trial of bilateral fetal nigral transplantation in Parkinson's disease.
C Warren Olanow, Christopher G Goetz, Jeffrey H Kordower, A Jon Stoessl, Vesna Sossi, Mitchell F Brin, Kathleen M Shannon, G Michael Nauert, Daniel P Perl, James Godbold,[...]. Ann Neurol 2003
33

Intracellular and extracellular microtubule associated protein tau as a therapeutic target in Alzheimer disease and other tauopathies.
Jesús Avila, Noemí Pallas, Marta Bolós, C Laura Sayas, Felix Hernandez. Expert Opin Ther Targets 2016
17
33

The neogenin/DCC homolog UNC-40 promotes BMP signaling via the RGM protein DRAG-1 in C. elegans.
Chenxi Tian, Herong Shi, Shan Xiong, Fenghua Hu, Wen-Cheng Xiong, Jun Liu. Development 2013
25
33

Diagnosis and Treatment of Parkinson Disease: A Review.
Melissa J Armstrong, Michael S Okun. JAMA 2020
452
33


Randomized controlled trial of intraputamenal glial cell line-derived neurotrophic factor infusion in Parkinson disease.
Anthony E Lang, Steven Gill, Nik K Patel, Andres Lozano, John G Nutt, Richard Penn, David J Brooks, Gary Hotton, Elena Moro, Peter Heywood,[...]. Ann Neurol 2006
691
33

Selegiline delays the onset of disability in de novo parkinsonian patients. Swedish Parkinson Study Group.
S Pålhagen, E H Heinonen, J Hägglund, T Kaugesaar, H Kontants, O Mäki-Ikola, R Palm, J Turunen. Neurology 1998
103
33

Is Braak staging valid for all types of Parkinson's disease?
Kurt A Jellinger. J Neural Transm (Vienna) 2019
45
33

Neuronal precursor cells with dopaminergic commitment in the rostral migratory stream of the mouse.
Kerstin Schweyer, Corinna Rüschoff-Steiner, Oscar Arias-Carrión, Wolfgang H Oertel, Thomas W Rösler, Günter U Höglinger. Sci Rep 2019
8
33

Targeting repulsive guidance molecule A to promote regeneration and neuroprotection in multiple sclerosis.
Elena Demicheva, Yi-Fang Cui, Philip Bardwell, Stefan Barghorn, Martina Kron, Axel H Meyer, Martin Schmidt, Björn Gerlach, Mary Leddy, Eve Barlow,[...]. Cell Rep 2015
45
33

Multiplicity of α-Synuclein Aggregated Species and Their Possible Roles in Disease.
Pablo Gracia, José D Camino, Laura Volpicelli-Daley, Nunilo Cremades. Int J Mol Sci 2020
16
33


Slower progression of Parkinson's disease with ropinirole versus levodopa: The REAL-PET study.
Alan L Whone, Ray L Watts, A Jon Stoessl, Margaret Davis, Sven Reske, Claude Nahmias, Anthony E Lang, Olivier Rascol, Maria J Ribeiro, Philippe Remy,[...]. Ann Neurol 2003
600
33

Randomized Delayed-Start Trial of Levodopa in Parkinson's Disease.
Constant V M Verschuur, Sven R Suwijn, Judith A Boel, Bart Post, Bas R Bloem, Johannes J van Hilten, Teus van Laar, Gerrit Tissingh, Alexander G Munts, Guenther Deuschl,[...]. N Engl J Med 2019
109
33


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.